Biologic Macromolecule Coating with Temporary Protective Layer

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Vascular stents often experience reocclusion due to injury to the endothelial cell lining, leading to thrombosis, infection, or abnormal tissue growth, as the biologic macromolecules used for promoting re-endothelialization can be deactivated during processing, storage, and sterilization due to denaturation.

Innovation Solution

A medical device with a coating of biologic macromolecules protected by a temporary water-soluble layer that dissolves within 24 hours after implantation, using low molecular weight carbohydrates to maintain the structure and function of the biologic macromolecules during processing and exposure to the physiological environment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If biologic macromolecules are coated on the medical device surface to promote re-endothelialization, then endothelial cell adhesion and biocompatibility are improved, but the biologic macromolecules can be deactivated during processing, storage, and sterilization due to denaturation

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidmacromolecule structure
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

A temporary protective layer is applied to the biologic macromolecules before the device undergoes processing, storage, and sterilization. This preliminary protective action prevents denaturation during these procedures, and the layer is designed to dissolve away before implantation so the macromolecules remain functional for promoting endothelialization

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

A water-soluble temporary protective layer serves as an intermediary between the biologic macromolecules and the harsh processing/sterilization environment. This intermediary layer protects the macromolecules from direct exposure to denaturing conditions while being removable before the device is used in the body

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If a protective layer is added to preserve biologic macromolecules during processing and storage, then macromolecule functionality is maintained, but the device complexity increases

Engineering Contradiction:
Improvemacromolecule functionalityVSAvoidcoating structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The temporary protective layer is designed to be discarded (dissolve away) before implantation. This allows the layer to provide protection during manufacturing and storage, then automatically disappear to reveal the functional macromolecule coating without requiring additional removal steps in the clinical setting

Inventive Principle:
Principle #34Discarding and recovering

Solution Approach 2:

The temporary protective layer is designed as a short-living, disposable component that serves its protective function only during manufacturing and storage, then dissolves away. This allows use of simple water-soluble materials that don't need to be permanent or complex

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The temporary protective layer effectively preserves the biologic macromolecules' functionality, allowing for rapid activation and adherence of endothelial cells upon implantation, thereby enhancing the biocompatibility and reducing reocclusion risks.

Implementation Method 1

the temporary protective layer substantially dissolves within 24 hours after implantation or insertion of the medical device in a patient

Methodology Applied
Scientific EffectDissolution: Solvation

Implementation Method 2

endothelial cells must migrate from adjacent areas of the artery and adhere onto the surface of the stent

Methodology Applied
Scientific EffectAdhesion: Adhesive

Data Source

PatentUS8574612B2Medical devices having a coating of biologic macromolecules
Publication Date: 2013.11.05 BOSTON SCIENTIFIC SCIMED INC
  • US8574612B2 patent drawing

AI summary

A medical device having a coating of biologic macromolecules. The coating of biologic macromolecules is protected by a temporary protective layer disposed over the biologic macromolecules. The temporary protective layer serves to protect the structure (e.g., conformation) and/or function (e.g., target binding capacity) of the biologic macromolecules during processing, storage, handling, and/or delivery (e.g., implantation or insertion into a patient) of the medical device. Upon implantation or insertion into a patient's body, the temporary protective layer may dissolve to expose the biologic macromolecules to the physiologic environment.